| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |